RxDoctor Payments Data

Albert Liu

Cardiovascular Disease · San Francisco, CANPI 1982067336

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.8%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 42.6% of the total.

$20,343in general payments, 2019–2025

Across 204 payments — averaging $99.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Abbott$4K
  • Boston Scientific$3K
  • Biosense Webster, Inc.$3K
  • Sanofi-aventis U.S. LLC$438
  • Philips North America LLC$414
  • plus $879 from 9 others
$435,156in research payments, 2019–2025

Across 2 payments — averaging $217,578 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$435K

What the payments were for

  • Grants$4,55822%
  • Travel & lodging$6,99834%
  • Food & beverage$8,10140%
  • Education$6873%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,343 in reported general payments places this provider in the 85th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Other cardiovascular disease in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →